Sponsored by
Although it was only a small phase 1 trial, they reported that the overall survival doubled compared to historical controls. This is now in a large phase 2/3 trial throughout the USA. We are working on raising funds to help speed up the approval process so all brain tumor patients could get access. Eventually, this may work for not only brain but most other types of cancer.